Tag: process capability

Addressing Commercial Scale Validation Protocols Using Pilot Data In the pharmaceutical industry, transitioning from pilot to commercial scale is fraught with risks that can impact product integrity, patient safety, and…

Managing Risks During the Transition from Pilot to Commercial Scale in Pharmaceutical Manufacturing The transition from pilot-scale production to commercial manufacturing is often fraught with challenges that can impact product…

Assessing the Necessity for Additional Scale-Up Batches in Pharma Manufacturing When transitioning from pilot to commercial scale, manufacturers often encounter unforeseen challenges, especially regarding batch quality and process consistency. The…

Best Practices for Handling Deviations During the Transition from Pilot to Commercial Scale Transitioning from pilot to commercial scale in pharmaceutical manufacturing entails various risks and complexities that can lead…

Best Practices for Handling Deviations in Pilot-to-Commercial Scale Manufacturing In the transition from pilot to commercial scale manufacturing, deviations can significantly impact product quality and regulatory compliance. These deviations, if…

Ensuring Robustness in Commercial Scale Processes: Key Verifications Before PPQ The transition from pilot to commercial scale in pharmaceutical manufacturing presents significant risks that, if unaddressed, can lead to product…

Addressing Sterility Assurance Risks During Commercial Scale-Up Scaling up manufacturing processes from pilot to commercial scale is fraught with challenges, particularly concerning sterility assurance. The risks can manifest as contamination…

Managing Content Uniformity Challenges During Scale-Up from Pilot to Commercial Production In the pharmaceutical industry, the transition from pilot to commercial scale manufacturing is fraught with potential risks, especially regarding…

Strategies for Managing Dissolution Drift in Commercial Scale-Up As pharmaceutical companies transition from pilot projects to commercial-scale manufacturing, maintaining consistent drug release profiles becomes critical. Dissolution drift—a phenomenon where the…

Effective Strategies for Minimizing Yield Loss During Commercial Scale-Up In the complex world of pharmaceutical manufacturing, transitioning from pilot to commercial scale often presents significant challenges that can lead to…

Strategies to Mitigate Yield Loss During the Transition from Pilot to Commercial Scale The transition from pilot to commercial scale manufacturing presents unique challenges, not least the risk of yield…

Mitigating Risks in Transitioning from Pilot to Commercial Scale Manufacturing The transition from pilot to commercial scale manufacturing is fraught with challenges that can significantly impact the quality and performance…